TABLE 1.
Summary of the various antibodies used
| Controls, cells, or expt | Antibody(-ies)a | Clone(s) | Company |
|---|---|---|---|
| Autofluorescence control | None added | ||
| Isotype controls | IgG1-PE, IgG2a-FITC | 2T8-2F5, 7T4-1F5 | Coulter Corp. |
| IgG2b-PE | X39 | Becton Dickinson | |
| Color compensation controls | Anti-CD14–FITC, anti-CD4–PE, anti-HLA-DR–TRIb | ||
| Monocytes | Anti-CD14–PE | LeuM3 | Becton Dickinson |
| Mo-2 | Coulter Corp. | ||
| Anti-CD14–FITC | MY4 | Coulter Corp. | |
| Anti-CD4–PE | T4 | Coulter Corp. | |
| Q4120 | Sigma | ||
| Anti-HLA-DR–FITC | L243 | Becton Dickinson | |
| Anti-HLA-DR–TRI | TU-36 | Caltag Laboratories, San Francisco, Calif. | |
| Combinations: two color, anti-CD14–anti-CD4 and anti-CD14–anti-HLA-DR; three-color, anti-CD14–anti-CD4–anti-HLA-DR | |||
| T cells | Anti-CD3–ECD | HIT3A | Coulter Corp. |
| Anti-CD3–FITC | Leu4 | Becton Dickinson | |
| Anti-CD3–TRI | S4.1 | Caltag Laboratories | |
| Anti-CD3–Quantum Red | UCHT-1 | Sigma | |
| Anti-CD4–PE | Various clones as described for monocytes | ||
| Anti-CD3–anti-CD4 combination | |||
| B cells | Anti-CD19–ECD | HD237 | Coulter Corp. |
| Anti-CD19–FITC | SJ25-C1 | Sigma | |
| FMC63 | Serotec, Mississauga, Ontario, Canada | ||
| Anti-CD20–PE | Leu16 | Becton Dickinson | |
| Anti-HLA-DR | Various clones as described for monocytes | ||
| Combinations: anti-CD19–anti-HLA-DR and/or anti-CD20–anti-HLA-DR | |||
| CD4 tagging experiments | Goat anti-mouse Ig–FITC | Not applicable | Biosource International, Camarillo, Calif. |
TRI and Quantum Red are Cy5-PE tandem dyes. ECD, energy-coupled dye.
Color compensation was performed on whole-blood monocytes. For each fluorochrome, the antibody which would result in the highest-intensity stain was used.